• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic Factors Associated With Mortality of Patients With COVID-19 Requiring Ventilator Management: A Retrospective Cohort Study.与需要呼吸机管理的COVID-19患者死亡率相关的预后因素:一项回顾性队列研究。
Cureus. 2022 May 26;14(5):e25374. doi: 10.7759/cureus.25374. eCollection 2022 May.
2
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.新型冠状病毒肺炎所致危重症:南达科他州苏福尔斯市某单一中心的激增情况描述
S D Med. 2020 Jul;73(7):312-317.
5
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.西班牙感染新型冠状病毒肺炎(SARS-CoV-2)的危重症患者的特征、临床病程及与重症监护病房(ICU)死亡率相关的因素:一项前瞻性队列多中心研究
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13.
6
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
7
Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.东京重症 COVID-19 患者的临床特征和结局:来自第一波的单中心观察性研究。
BMC Infect Dis. 2021 Feb 9;21(1):163. doi: 10.1186/s12879-021-05840-2.
8
Incidence of Thrombotic Events and Outcomes in COVID-19 Patients Admitted to Intensive Care Units.入住重症监护病房的新冠患者血栓形成事件及转归的发生率
Cureus. 2020 Oct 21;12(10):e11079. doi: 10.7759/cureus.11079.
9
Clinical characteristics and outcomes of critically ill patients with COVID-19 in Kobe, Japan: a single-center, retrospective, observational study.日本神户市 COVID-19 重症患者的临床特征和结局:一项单中心、回顾性、观察性研究。
J Anesth. 2021 Apr;35(2):213-221. doi: 10.1007/s00540-021-02897-w. Epub 2021 Jan 23.
10
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.在一个多机构医疗系统中,2019冠状病毒病检测呈阳性的住院患者发生深静脉血栓形成和肺栓塞预示着更高的死亡率以及更长的重症监护病房住院时间和医院住院时间。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6.

引用本文的文献

1
Prolonged loss of intercostal muscle mass and its predictors in COVID-19 patients: A retrospective study from tertiary hospital.COVID-19 患者肋间肌量长期丢失及其预测因素:来自三甲医院的回顾性研究。
Medicine (Baltimore). 2024 May 31;103(22):e38284. doi: 10.1097/MD.0000000000038284.
2
Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis.合并哮喘增加亚洲地区2019冠状病毒病死亡风险:一项荟萃分析
Vaccines (Basel). 2022 Dec 30;11(1):89. doi: 10.3390/vaccines11010089.

本文引用的文献

1
Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.COVID-19 感染患者出院后接受地塞米松治疗与再入院和死亡率的关系。
JAMA Netw Open. 2022 Mar 1;5(3):e221455. doi: 10.1001/jamanetworkopen.2022.1455.
2
Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.接受重症监护或加强护理的 COVID-19 感染患者的护理和临床结局:一项多中心、前瞻性、观察性队列研究。
Lancet. 2021 May 22;397(10288):1885-1894. doi: 10.1016/S0140-6736(21)00441-4.
3
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
4
Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.新冠肺炎危重症患者的多系统结局和死亡率预测因素:人口统计学和疾病严重程度比合并症或治疗方式更重要。
J Trauma Acute Care Surg. 2021 May 1;90(5):880-890. doi: 10.1097/TA.0000000000003085.
5
Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months.COVID-19 重症成年患者 8 个月内 13301 例病死率的演变变化。
Intensive Care Med. 2021 May;47(5):538-548. doi: 10.1007/s00134-021-06388-0. Epub 2021 Apr 14.
6
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.托珠单抗治疗重症 COVID-19 肺炎住院患者。
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
7
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
8
Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States.美国学习型医疗系统中 COVID-19 相关危重症患者的特征、结局和趋势。
Ann Intern Med. 2021 May;174(5):613-621. doi: 10.7326/M20-5327. Epub 2021 Jan 19.
9
Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients.ICU 中的发热:机械通气 COVID-19 患者死亡的预测因素。
J Intensive Care Med. 2021 Apr;36(4):484-493. doi: 10.1177/0885066620979622. Epub 2020 Dec 15.
10
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.

与需要呼吸机管理的COVID-19患者死亡率相关的预后因素:一项回顾性队列研究。

Prognostic Factors Associated With Mortality of Patients With COVID-19 Requiring Ventilator Management: A Retrospective Cohort Study.

作者信息

Kuwahara Masaatsu, Kamigaito Misa, Murakami Hiromoto, Sato Kiyoko, Mambo Naomi, Kobayashi Tomoyuki, Shirai Kunihiro, Miyawaki Atsushi, Ohya Munehiko, Hirata Jun-Ichi

机构信息

Department of Emergency and Critical Care Medicine, Hyogo College of Medicine, Nishinomiya, JPN.

出版信息

Cureus. 2022 May 26;14(5):e25374. doi: 10.7759/cureus.25374. eCollection 2022 May.

DOI:10.7759/cureus.25374
PMID:35774696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9236674/
Abstract

Aim There are few reports on the prognostic factors associated with mortality in coronavirus disease (COVID-19) patients with critical disease. This study assessed prognostic factors associated with mortality of patients with critical COVID-19 who required ventilator management. Methods This single-center, retrospective cohort study used medical record data of COVID-19 patients admitted to an emergency ICU at a hospital in Japan between March 1, 2020 and September 30, 2021, and provided with ventilator management. Multivariable logistic regression was used to identify factors associated with mortality. Results Seventy patients were included, of whom 29 (41.4%) died. The patients who died were significantly older (median: 69 years) (interquartile range [IQR]: 47-82 years) than the patients who survived (62 years [38-84 years], p<0.007). In addition, patients who died were significantly less likely to have received steroid therapy than patients who survived (25 [86.2%] vs. 41 [100%], p=0.026). In the multivariable analysis, age was identified as a significant prognostic factor for mortality and the risk of death increased by 6% for every one-year increase in age (OR: 1.06; 95% CI: 1.00-1.13; p=0.048). Medical history was not a risk factor for death. Conclusion Age was a predictor of mortality in critically ill patients with COVID-19. Therefore, the indications for critical care in older patients with COVID-19 should be carefully considered.

摘要

目的 关于危重型冠状病毒病(COVID-19)患者死亡相关预后因素的报道较少。本研究评估了需要呼吸机管理的危重型COVID-19患者死亡的预后因素。方法 本单中心回顾性队列研究使用了2020年3月1日至2021年9月30日期间在日本一家医院急诊重症监护病房收治并接受呼吸机管理的COVID-19患者的病历数据。采用多变量逻辑回归分析确定与死亡相关的因素。结果 共纳入70例患者,其中29例(41.4%)死亡。死亡患者的年龄显著大于存活患者(中位数:69岁)(四分位间距[IQR]:47 - 82岁)(存活患者为62岁[38 - 84岁],p<0.007)。此外,死亡患者接受类固醇治疗的可能性显著低于存活患者(25例[86.2%]对41例[100%],p = 0.026)。在多变量分析中,年龄被确定为死亡的显著预后因素,年龄每增加一岁,死亡风险增加6%(比值比:1.06;95%置信区间:1.00 - 1.13;p = 0.048)。病史不是死亡的危险因素。结论 年龄是危重型COVID-19患者死亡的预测因素。因此,对于老年COVID-19患者的重症监护指征应谨慎考虑。